Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Gynecologic Oncology Reports|June 7, 2021
Ovarian cancer with high-level focal <i>ERBB2</i> amplification responds to trastuzumab and pertuzumabLaure Thouvenin, Mélinda Charrier, Sophie Clement, et al.NPJ Precision Oncology|August 14, 2024
Probing the killing potency of tumor-infiltrating lymphocytes on microarrayed colorectal cancer tumoroidsDevanjali Dutta, L Francisco Lorenzo-Martín, François Rivest, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Tissue specificity and chromosomal alterations shape divergent immune programs in HRD tumorsDoga C Gulhan, David Barras, Marco Mina, et al.Cancers|May 14, 2022
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced MelanomaKrisztian Homicsko, Reinhard Dummer, Christoph Hoeller, et al.Journal of Neuro-Oncology|December 15, 2019
The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective studyFilipe Martins, Luis Schiappacasse, Marc Levivier, et al.Cancers|January 8, 2023
Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic MelanomaBianca Gautron Moura, Camille L Gerard, Nathalie Testart, et al.Journal for Immunotherapy of Cancer|January 16, 2026
Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumorsIgnacio Melero, Neeltje Steeghs, Ulrik Lassen, et al.Science Translational Medicine|September 15, 2017
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanomaManuel Fankhauser, Maria A S Broggi, Lambert Potin, et al.Nature Medicine|April 16, 2013
A colorectal cancer classification system that associates cellular phenotype and responses to therapyAnguraj Sadanandam, Costas A Lyssiotis, Krisztian Homicsko, et al.Cell|March 31, 2023
A neutrophil response linked to tumor control in immunotherapyJeremy Gungabeesoon, Nicolas A Gort-Freitas, Máté Kiss, et al.Pageof 6